DK1392347T3 - Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteiner - Google Patents
Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteinerInfo
- Publication number
- DK1392347T3 DK1392347T3 DK02729699T DK02729699T DK1392347T3 DK 1392347 T3 DK1392347 T3 DK 1392347T3 DK 02729699 T DK02729699 T DK 02729699T DK 02729699 T DK02729699 T DK 02729699T DK 1392347 T3 DK1392347 T3 DK 1392347T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell death
- proteins
- segments
- preventing cell
- tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29097101P | 2001-05-16 | 2001-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1392347T3 true DK1392347T3 (da) | 2005-12-12 |
Family
ID=23118262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02729699T DK1392347T3 (da) | 2001-05-16 | 2002-05-16 | Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteiner |
Country Status (13)
Country | Link |
---|---|
US (1) | US7572450B2 (es) |
EP (1) | EP1392347B1 (es) |
JP (1) | JP2004529179A (es) |
KR (1) | KR20040008177A (es) |
CN (1) | CN1558770A (es) |
AT (2) | ATE381342T1 (es) |
BR (1) | BR0209630A (es) |
CA (1) | CA2446945A1 (es) |
DE (2) | DE60205366T2 (es) |
DK (1) | DK1392347T3 (es) |
ES (1) | ES2247329T3 (es) |
HK (1) | HK1060851A1 (es) |
WO (1) | WO2002092115A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7259232B1 (en) * | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
BR0209990A (pt) * | 2001-05-25 | 2004-06-29 | Nymox Corp | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células |
US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
US20160361380A1 (en) * | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
US11628202B2 (en) * | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2094733T3 (es) * | 1988-12-21 | 1997-02-01 | Gen Hospital Corp | Deteccion de enfermedades o disfunciones neurologicas. |
US5948634A (en) * | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
DK1564293T3 (da) | 1993-04-20 | 2009-01-12 | Gen Hospital Corp | Nervetrådproteingenekspression og detektion af Alzheimers sygdom |
CN1300779A (zh) | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽-人神经元线蛋白17和编码这种多肽的多核苷酸 |
CN1300778A (zh) | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | 一种新的多肽-人神经元线蛋白15和编码这种多肽的多核苷酸 |
US7259232B1 (en) | 2000-10-27 | 2007-08-21 | Nymox Pharmaceutical Corporation | Preferred segments of neural thread protein |
EP1368054B1 (en) | 2001-03-08 | 2007-10-03 | Nymox Pharmaceutical Corporation | Using neural thread proteins to treat tumors |
-
2002
- 2002-05-16 BR BR0209630-7A patent/BR0209630A/pt not_active IP Right Cessation
- 2002-05-16 CN CNA02814029XA patent/CN1558770A/zh active Pending
- 2002-05-16 DE DE60205366T patent/DE60205366T2/de not_active Expired - Fee Related
- 2002-05-16 JP JP2002589032A patent/JP2004529179A/ja not_active Ceased
- 2002-05-16 AT AT05003125T patent/ATE381342T1/de not_active IP Right Cessation
- 2002-05-16 EP EP02729699A patent/EP1392347B1/en not_active Expired - Lifetime
- 2002-05-16 ES ES02729699T patent/ES2247329T3/es not_active Expired - Lifetime
- 2002-05-16 DE DE60224231T patent/DE60224231D1/de not_active Expired - Lifetime
- 2002-05-16 KR KR10-2003-7014850A patent/KR20040008177A/ko active IP Right Grant
- 2002-05-16 CA CA002446945A patent/CA2446945A1/en not_active Abandoned
- 2002-05-16 WO PCT/CA2002/000712 patent/WO2002092115A2/en active IP Right Grant
- 2002-05-16 DK DK02729699T patent/DK1392347T3/da active
- 2002-05-16 US US10/146,130 patent/US7572450B2/en not_active Expired - Fee Related
- 2002-05-16 AT AT02729699T patent/ATE300951T1/de not_active IP Right Cessation
-
2004
- 2004-05-31 HK HK04103880A patent/HK1060851A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1060851A1 (en) | 2004-08-27 |
CN1558770A (zh) | 2004-12-29 |
CA2446945A1 (en) | 2002-11-21 |
JP2004529179A (ja) | 2004-09-24 |
WO2002092115A2 (en) | 2002-11-21 |
US20030004107A1 (en) | 2003-01-02 |
ATE300951T1 (de) | 2005-08-15 |
DE60205366D1 (de) | 2005-09-08 |
ES2247329T3 (es) | 2006-03-01 |
WO2002092115A3 (en) | 2003-05-15 |
EP1392347A2 (en) | 2004-03-03 |
EP1392347B1 (en) | 2005-08-03 |
US7572450B2 (en) | 2009-08-11 |
ATE381342T1 (de) | 2008-01-15 |
BR0209630A (pt) | 2004-03-30 |
DE60205366T2 (de) | 2006-05-24 |
KR20040008177A (ko) | 2004-01-28 |
DE60224231D1 (de) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1392347T3 (da) | Fremgangsmåde til at forhindre celledöd med anvendelse af segmenter af neurale trådproteiner | |
PL402389A1 (pl) | Sposób hamowania aktywnosci kinazy Raf u ludzi lub zwierzat | |
ATE303162T1 (de) | Natrium kanalblocker zusammensetzungen und deren verwendung | |
DE60143520D1 (de) | Inhibitoren der histon-deacetylase | |
DK1233958T3 (da) | Hæmmere af histondeacetylase | |
BR0304648A (pt) | Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia | |
DE69936102D1 (de) | Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden | |
ATE297731T1 (de) | Metall chelatoren zur verwendung in der behandlung von alzheimers erkrankung mit clioquinol | |
EA200401341A1 (ru) | Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания | |
NZ516562A (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
ATE329622T1 (de) | Steigerung der antikörper-zytokin- fusionsproteinmediierten immunantwort durch mitverabreichung mit einem angiogeneseinhibitor | |
ATE278399T1 (de) | Orotatsalze von 5-amino- oder substituierten amino-1,2,3-triazolen zur behandlung von neoplasmen | |
DK2009025T3 (da) | Fremgangsmåde til hæmning af osteoklast-aktivitet | |
ATE554169T1 (de) | Smad7-inhibitoren zur behandlung von krankheiten des zns | |
BRPI0600195A (pt) | composição aquosa | |
DK0752813T3 (da) | Hæmmere af metozoan-parasit-proteaser | |
NO996555D0 (no) | Fremgangsmåte ved inhibering av nedbrytning fremmet av sulfat- reduserende bakterier | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
EP0916344A3 (en) | Nef action inhibitor | |
DK1183037T3 (da) | Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdomme | |
HUP0102259A2 (hu) | Eljárás korrózió gátlására klór-metil-benzotriazol izomerek alkalmazásával | |
BR0213357A (pt) | Compostos orgânicos | |
EA199900479A1 (ru) | Стабилизированные фармацевтические композиции на основе хинупристина и дальфопристина и способ получения | |
WO2003102148A3 (en) | Human prolactin antagonist-angiogenesis inhibitor fusion proteins | |
ES2144513T3 (es) | Inhibicion de crecimiento tumoral inducido por traumatismo. |